Fineline Cube

Follow:
14486 Articles
Bio-Thera Solutions Inks Licensing Deal with World Medicine for BAT2206
CompanyDeals

Bio-Thera Solutions Inks Licensing Deal with World Medicine for BAT2206

Hainan Poly Pharm's US Partner Slate Run Pharmaceuticals Collaborates with Premier on Contrast Agents
CompanyDeals

Hainan Poly Pharm’s US Partner Slate Run Pharmaceuticals Collaborates with Premier on Contrast Agents

Gensaic and Novo Nordisk Team Up to Develop Cardiometabolic Therapies
CompanyDeals

Gensaic and Novo Nordisk Team Up to Develop Cardiometabolic Therapies

MSD China Reorganizes to Boost Mature Product Lines
Company

MSD China Reorganizes to Boost Mature Product Lines

Suzhou Abogen's RSV mRNA Vaccine IND Approved by China's CDE
CompanyDrug

Suzhou Abogen’s RSV mRNA Vaccine IND Approved by China’s CDE

CDE Launches SPARK Project to Boost Pediatric Antitumor Drug R&D
Policy / Regulatory

CDE Launches SPARK Project to Boost Pediatric Antitumor Drug R&D

BeiGene's Tevimbra Receives FDA Approval for ESCC Treatment
CompanyDrug

BeiGene’s Tevimbra Receives FDA Approval for ESCC Treatment

Organon's 2024 Financial Report Shows Steady Growth in Women's Health and Biosimilars
Company

Organon’s 2024 Financial Report Shows Steady Growth in Women’s Health and Biosimilars

AstraZeneca and Daiichi Sankyo's Enhertu Shows Positive Results in Phase III Study
CompanyDrug

AstraZeneca and Daiichi Sankyo’s Enhertu Shows Positive Results in Phase III Study

Boehringer Ingelheim Appeals CNIPA's Invalidation of Jardiance Patents
Company

Boehringer Ingelheim Appeals CNIPA’s Invalidation of Jardiance Patents

Genentech's TNKase Approved by FDA for Acute Ischemic Stroke Treatment
CompanyDrug

Genentech’s TNKase Approved by FDA for Acute Ischemic Stroke Treatment

Eisai's Lecanemab Rejected by Australia's TGA for Early Alzheimer's Treatment
CompanyDrug

Eisai’s Lecanemab Rejected by Australia’s TGA for Early Alzheimer’s Treatment